IE912312A1 - Sulfur-substituted mevinic acid derivatives - Google Patents
Sulfur-substituted mevinic acid derivativesInfo
- Publication number
- IE912312A1 IE912312A1 IE231291A IE231291A IE912312A1 IE 912312 A1 IE912312 A1 IE 912312A1 IE 231291 A IE231291 A IE 231291A IE 231291 A IE231291 A IE 231291A IE 912312 A1 IE912312 A1 IE 912312A1
- Authority
- IE
- Ireland
- Prior art keywords
- acid
- decahydro
- methyl
- dihydroxy
- oxobutoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/20—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D309/22—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54902490A | 1990-07-06 | 1990-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
IE912312A1 true IE912312A1 (en) | 1992-01-15 |
Family
ID=24191347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE231291A IE912312A1 (en) | 1990-07-06 | 1991-07-02 | Sulfur-substituted mevinic acid derivatives |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0465265A1 (en:Method) |
JP (1) | JPH04230357A (en:Method) |
KR (1) | KR920002571A (en:Method) |
CN (1) | CN1058585A (en:Method) |
AU (1) | AU647492B2 (en:Method) |
CA (1) | CA2046171A1 (en:Method) |
CS (1) | CS207191A3 (en:Method) |
FI (1) | FI913285A7 (en:Method) |
HU (1) | HUT58682A (en:Method) |
IE (1) | IE912312A1 (en:Method) |
IL (1) | IL98721A0 (en:Method) |
MX (1) | MX9100095A (en:Method) |
MY (1) | MY106564A (en:Method) |
NO (1) | NO912636L (en:Method) |
NZ (1) | NZ238848A (en:Method) |
PL (2) | PL290954A1 (en:Method) |
PT (1) | PT98246A (en:Method) |
RU (1) | RU2041205C1 (en:Method) |
TW (1) | TW227552B (en:Method) |
ZA (1) | ZA915171B (en:Method) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5369123A (en) * | 1992-10-09 | 1994-11-29 | E. R. Squibb & Sons, Inc. | Nitrogen-substituted mevinic acid derivatives useful as HMG-CoA reductase inhibitors |
US6043064A (en) * | 1993-10-22 | 2000-03-28 | Bristol-Myers Squibb Company | Enzymatic hydroxylation process for the preparation of HMG-CoA reductase inhibitors and intermediates thereof |
GB2329334A (en) * | 1997-09-18 | 1999-03-24 | Reckitt & Colmann Prod Ltd | Cholesterol-lowering agents |
US20210008084A1 (en) | 2017-10-16 | 2021-01-14 | Tsinghua University | Mevalonate pathway inhibitor and pharmaceutical composition thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT88364A (pt) * | 1987-09-02 | 1989-07-31 | Merck & Co Inc | Process for preparing novel hmg-coa reductase inhibitors |
US4866090A (en) * | 1988-01-07 | 1989-09-12 | Merck & Co., Inc. | Novel HMG-CoA reductase inhibitors |
FI893004L (fi) * | 1988-06-29 | 1989-12-30 | Merck & Co Inc | 5-oxygenerade hmg-coa-reduktas -inhibitorer. |
EP0415488B1 (en) * | 1989-08-31 | 1994-04-20 | Merck & Co. Inc. | 7-Substituted HMG-COA reductase inhibitors |
-
1991
- 1991-06-15 TW TW080104670A patent/TW227552B/zh active
- 1991-06-15 MY MYPI91001079A patent/MY106564A/en unknown
- 1991-07-02 IE IE231291A patent/IE912312A1/en unknown
- 1991-07-03 AU AU80120/91A patent/AU647492B2/en not_active Ceased
- 1991-07-03 ZA ZA915171A patent/ZA915171B/xx unknown
- 1991-07-04 IL IL98721A patent/IL98721A0/xx unknown
- 1991-07-04 CS CS912071A patent/CS207191A3/cs unknown
- 1991-07-04 CA CA002046171A patent/CA2046171A1/en not_active Abandoned
- 1991-07-05 KR KR1019910011385A patent/KR920002571A/ko not_active Withdrawn
- 1991-07-05 NZ NZ238848A patent/NZ238848A/xx unknown
- 1991-07-05 EP EP91306125A patent/EP0465265A1/en not_active Ceased
- 1991-07-05 JP JP3165683A patent/JPH04230357A/ja not_active Withdrawn
- 1991-07-05 RU SU915001316A patent/RU2041205C1/ru active
- 1991-07-05 HU HU912287A patent/HUT58682A/hu unknown
- 1991-07-05 FI FI913285A patent/FI913285A7/fi not_active Application Discontinuation
- 1991-07-05 PL PL29095491A patent/PL290954A1/xx unknown
- 1991-07-05 MX MX9100095A patent/MX9100095A/es unknown
- 1991-07-05 NO NO91912636A patent/NO912636L/no unknown
- 1991-07-05 PL PL29514991A patent/PL295149A1/xx unknown
- 1991-07-06 CN CN91105317A patent/CN1058585A/zh active Pending
- 1991-07-08 PT PT98246A patent/PT98246A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CS207191A3 (en) | 1992-04-15 |
TW227552B (en:Method) | 1994-08-01 |
HUT58682A (en) | 1992-03-30 |
ZA915171B (en) | 1992-06-24 |
FI913285A0 (fi) | 1991-07-05 |
EP0465265A1 (en) | 1992-01-08 |
MX9100095A (es) | 1992-02-28 |
NO912636L (no) | 1992-01-07 |
PT98246A (pt) | 1992-05-29 |
CA2046171A1 (en) | 1992-01-07 |
KR920002571A (ko) | 1992-02-28 |
CN1058585A (zh) | 1992-02-12 |
PL295149A1 (en) | 1992-11-30 |
IL98721A0 (en) | 1992-07-15 |
HU912287D0 (en) | 1991-12-30 |
AU647492B2 (en) | 1994-03-24 |
NO912636D0 (no) | 1991-07-05 |
JPH04230357A (ja) | 1992-08-19 |
NZ238848A (en) | 1993-06-25 |
RU2041205C1 (ru) | 1995-08-09 |
AU8012091A (en) | 1992-01-09 |
FI913285A7 (fi) | 1992-01-07 |
MY106564A (en) | 1995-06-30 |
PL290954A1 (en) | 1992-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5260290A (en) | Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives | |
AU2007207481A1 (en) | Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors | |
IE71227B1 (en) | 24-homo vitamin D derivatives process for their production and pharmaceutical preparations obtained therefrom | |
WO1993012123A1 (en) | 3-carboxy-2-hydroxy-propane-phosphonic acid derivatives | |
CZ12999A3 (cs) | Analogy illudinu a farmaceutický prostředek | |
WO2023160039A1 (zh) | 具有HDACi药效团的β-榄香烯衍生物及其制备方法和应用 | |
US4874877A (en) | Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs | |
IE912312A1 (en) | Sulfur-substituted mevinic acid derivatives | |
AU619563B2 (en) | 5-oxygenated HMG-CoA reductase inhibitors | |
US5264455A (en) | Sulfur-substituted mevinic acid derivatives | |
Rizzo et al. | Aphidicolin synthetic studies: a stereocontrolled end game | |
US5177104A (en) | 6-α-hydroxy derivatives of mevinic acids | |
AU2767292A (en) | Cyclic peroxyacetal compounds | |
Bisht et al. | Domino reactions of alkenyl p-benzoquinones: Access to aryl sulfide derivatives of coumarins | |
US5089523A (en) | Fluorinated derivatives of mevinic acids | |
US5286746A (en) | Sulfur-substituted mevinic acid derivatives | |
FR2581997A1 (fr) | Analogues de prostaglandines a substituant thiabicycloheptane, a proprietes therapeutiques | |
ZA200506167B (en) | Novel anticonvulsant derivative salts | |
PL163376B1 (pl) | S p osób w y tw a r z a n ia p o ch o d n y ch p e n e m u PL PL PL | |
EP0251827A2 (en) | New cyclic ether derivatives, their preparation and their use | |
Frischmuth et al. | Strigol synthetic studies the problem of stereocontrol at C-2′ | |
JPH09512799A (ja) | チューブリン重合及び解重合に影響を与えるボルネオール誘導体 | |
EP0818443B1 (en) | Mercaptoketones and mercaptoalcohols, a process for their preparation and their use as inhibitors of matrix metalloproteinases | |
EP1426352A2 (en) | Intermediates for the sythesis of vitamin D and steroid derivatives | |
RU2068412C1 (ru) | Производное оксаспиро [2,5] октана и способ его получения (варианты) |